Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors

NCT07146672 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor Cancer

Interventions

BIOLOGICAL: Super DC Vaccine

Sponsor

Shanghai Cell Therapy Group Co.,Ltd